Astarte offers T cells purified from leukapheresed PBMC. Both negative and positive selection are available. Purity is ≥95% as assessed by flow cytometric analysis. Cell count is confirmed and viability is ≥85%.
| Catalog Number |
Description |
Cells per vial | Price per vial |
| CD3+ cells - Negative selection | 5-10 million |
$300 |
|
| CD4+ cells - Negative selection | 5-10 million |
$400 |
Before Selection
After Selection:
CD3+ T cells CD4+
